Bilthoven Biologicals
Stijn Van De Graaf is currently a Junior Research Technician at Bilthoven Biologicals, with a focus on Bacterial Bulk Production since September 2021. Prior experience includes a position at Le Barrage as an Afwasser from November 2019 to November 2021. Stijn is pursuing a Bachelor's degree in Life Sciences at HU University of Applied Sciences Utrecht, with studies taking place from September 2022 to September 2026. Previous education includes attendance at Techniek College Rotterdam from 2018 to 2022 and Da Vinci College Dordrecht in 2017-2018, where Stijn earned a qualification in Assistent bouwen, wonen en onderhoud.
This person is not in any offices
Bilthoven Biologicals
About Bilthoven Biologicals Bilthoven Biologicals is a biopharmaceutical company which produces Inactivated Polio Vaccines (IPV), Tetanus Vaccines, Diphtheria-Tetanus-Polio Vaccines (DT-PV) and Bacillus Calmette-Guérin (BCG) for the treatment of bladder cancer. We deliver our vaccines to UNICEF, with which we support the World Health Organisation (WHO) to eradicate polio. Bilthoven Biologicals has been part of the Cyrus Poonawalla Group since 2012, the world’s largest vaccine producer and employs more than 500 employees. www.bbio.nl | www.werkenbijbbio.nl | https://www.bbio.nl/en/what-we-produce/report-side-effects/ Over Bilthoven Biologicals Bilthoven Biologicals is een biofarmaceutisch bedrijf dat geïnactiveerde polio vaccins (IPV), Tetanus vaccins, Difterie-Tetanus-Polio vaccins (DT-IPV) produceert en Bacillus Calmette-Guérin (BCG) voor de behandeling van blaaskanker. Wij leveren onze vaccins aan UNICEF, waarmee wij de Wereldgezondheidsorganisatie (WHO) ondersteunen bij het uitroeien van polio. Bilthoven Biologicals is sinds 2012 onderdeel van de Cyrus Poonawalla Group, de grootste vaccinproducent ter wereld en heeft ruim 500 medewerkers. www.bbio.nl | www.werkenbijbbio.nl | https://www.bbio.nl/wat-wij-maken/bijwerkingen-melden/